In this study, tirzepatide persistence (73.3%) using a 45-day treatment gap was similar to that of dulaglutide (69.2%71.9%) and greater than that of semaglutide (59.2%62.2%) at 6 months reported previously in claims-based studies in patients with T2D newly initiating GLP-1 therapy [47, 48]
Aquilani R, Boselli M, Boschi F, Viglio S, Iadarola P, Dossena M, et al
Very caring provider who answered all of my questions
At this stage, the most responsible way to phrase the issue is: Retatrutide may become part of a more advanced generation of metabolic medications, but muscle preservation still depends on the full treatment plan including protein intake, resistance training, dose management, nutrition quality, sleep, hormones, and medical monitoring
Take the quiz Track your pregnancy, prep for what's next, and get expert support all for free
February is American Heart Month , a time dedicated to raising awareness about cardiovascular disease the leading cause of death for men and women in the United States
/product/02/3175523/1.jpg?6062)